Abiopharma

🔍 Hoppenot Herve (Director)

Company: INCYTE CORP (INCY)

Report Date: 2025-12-08

Detailed Transactions and Holdings:

• Sold 2,843 shares of Common Stock at $96.7 per share (Direct)
  Date: 2025-12-08 | Code: F | equity_swap_involved: 0 | shares_owned_after: 326,803.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.
• F2: This includes an aggregate of 70,643 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.